Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and other fungi in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; BIOFUN-4 targeting oomycetes in fruits and vegetables; BIOFUN-8 targeting altenaria in fruits, vegetables, and specialty crops; and BioIns-2 targeting key insect pests. The company was formerly known as Agrosavfe NV and changed its name to Biotalys NV in December 2019. Biotalys NV was incorporated in 2013 and is headquartered in Ghent, Belgium.
Frequently asked questions
What sector does Biotalys NV (BTLS) operate in?
Biotalys NV belongs to the Materials sector and operates in the Agricultural Inputs industry.
What is Biotalys NV (BTLS) current stock price?
As of the latest data, Biotalys NV stock price is €2.41, with a previous close of €2.46. Biotalys NV lost -€0.05 in the last trading session, representing a -1.83% loss.
What is Biotalys NV (BTLS) current market capitalization?
Biotalys NV market cap is approximately 109.52 million.
What is Biotalys NV (BTLS) Earnings Per Share (EPS)?
The trailing EPS is -€0.41, and the forward EPS is -€0.32.
Does Biotalys NV (BTLS) pay dividends?
No. Biotalys NV does not pay a dividend.
When is Biotalys NV (BTLS) next earnings report?
Biotalys NV is expected to release its next earnings report on June 30, 2026.
What is Biotalys NV (BTLS) beta (volatility) score?
Biotalys NV has a beta of 1.372, suggesting it is more volatile than the market.
